- Home
- HBIO vs CRIS Comparison
HBIO vs CRIS Comparison
Compare HBIO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- CRIS
- Stock Information
- Founded
- HBIO 1901
- CRIS 2000
- Country
- HBIO United States
- CRIS United States
- Employees
- HBIO N/A
- CRIS N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HBIO Industrials
- CRIS Health Care
- Exchange
- HBIO Nasdaq
- CRIS Nasdaq
- Market Cap
- HBIO 22.5M
- CRIS 21.3M
- IPO Year
- HBIO 2000
- CRIS 2000
- Fundamental
- Price
- HBIO $0.51
- CRIS $2.28
- Analyst Decision
- HBIO Buy
- CRIS Strong Buy
- Analyst Count
- HBIO 2
- CRIS 2
- Target Price
- HBIO $3.00
- CRIS $16.50
- AVG Volume (30 Days)
- HBIO 35.3M
- CRIS 75.5K
- Earning Date
- HBIO 08-07-2025
- CRIS 07-31-2025
- Dividend Yield
- HBIO N/A
- CRIS N/A
- EPS Growth
- HBIO N/A
- CRIS N/A
- EPS
- HBIO N/A
- CRIS N/A
- Revenue
- HBIO $91,397,000.00
- CRIS $11,202,000.00
- Revenue This Year
- HBIO N/A
- CRIS N/A
- Revenue Next Year
- HBIO $9.75
- CRIS $10.67
- P/E Ratio
- HBIO N/A
- CRIS N/A
- Revenue Growth
- HBIO N/A
- CRIS 14.17
- 52 Week Low
- HBIO $0.28
- CRIS $1.02
- 52 Week High
- HBIO $3.60
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- HBIO 54.14
- CRIS 50.37
- Support Level
- HBIO $0.47
- CRIS $2.11
- Resistance Level
- HBIO $0.55
- CRIS $2.26
- Average True Range (ATR)
- HBIO 0.07
- CRIS 0.20
- MACD
- HBIO -0.00
- CRIS -0.04
- Stochastic Oscillator
- HBIO 50.68
- CRIS 16.85
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.